From the Department of Medical Biology, Baskent University, Ankara, Turkey; and the Tissue Typing and Transplantation Laboratory, Baskent University, Adana, Turkey.
Exp Clin Transplant. 2020 Jan;18(Suppl 1):51-54. doi: 10.6002/ect.TOND-TDTD2019.O24.
The main function of HLA is to present antigens to lymphocytes and to initiate specific immune responses. Autoimmune, viral, allergic, and neurologic diseases have been found to be related to HLA molecules. In renal transplant, the main target of the recipient's immune system is the HLA molecules on the surface of donor cells. HLA also plays a role in the development of an immune response to viral infections. After renal transplant, BK virus infections may occur due to immunosuppression. Here, we investigated the relationship between HLA and BK virus in renal transplant recipients.
This retrospective study investigated HLA-A, HLA-B, and HLA-DR tissue typing before renal transplant. DNA was isolated from whole blood, and tissue typing tests were performed based on polymerase chain reaction. Patients were tested for BK virus posttransplant using DNA isolated from urine and/or plasma samples.
We found HLA-B13 allele to be a protective factor (P < .049; odds ratio: 0.131; 95% confidence interval, 0.017-1.029) and HLA-DRB103 allele to be a possible risk factor (P < .029; odds ratio: 2.521; 95% confidence interval, 1.157-5.490) against BK virus. No significant relationships were found between BK virus and age, sex, donor type, and HLA mismatch.
HLA class I molecules are known to be effective against viruses with the help of cytotoxic T cells. HLA-B13 alleles within the HLA class I molecules were identified as protective factors against BK virus. HLA class II is associated with CD4-positive T cells that help secrete immune system cytokines, playing a role in stimulating and suppressing the immune system. We demonstrated that HLA-DRB103 allele could be a risk factor against BK virus. This allele may be associated with immunomodulatory cytokine secretion of the immune system.
HLA 的主要功能是将抗原呈递给淋巴细胞,并启动特异性免疫反应。自身免疫、病毒、过敏和神经疾病已被发现与 HLA 分子有关。在肾移植中,受者免疫系统的主要靶标是供体细胞表面的 HLA 分子。HLA 还在对病毒感染的免疫反应发展中发挥作用。肾移植后,由于免疫抑制,可能会发生 BK 病毒感染。在这里,我们研究了 HLA 与肾移植受者 BK 病毒之间的关系。
这项回顾性研究调查了肾移植前 HLA-A、HLA-B 和 HLA-DR 组织分型。从全血中分离 DNA,并根据聚合酶链反应进行组织分型检测。使用从尿液和/或血浆样本中分离的 DNA 对移植后的 BK 病毒进行检测。
我们发现 HLA-B13 等位基因是一个保护因素(P <.049;优势比:0.131;95%置信区间,0.017-1.029),HLA-DRB103 等位基因是一个可能的危险因素(P <.029;优势比:2.521;95%置信区间,1.157-5.490)对 BK 病毒。未发现 BK 病毒与年龄、性别、供体类型和 HLA 错配之间存在显著关系。
HLA Ⅰ类分子在细胞毒性 T 细胞的帮助下对病毒有效。在 HLA Ⅰ类分子中发现 HLA-B13 等位基因是针对 BK 病毒的保护因素。HLA Ⅱ类与 CD4 阳性 T 细胞有关,这些细胞有助于分泌免疫系统细胞因子,在刺激和抑制免疫系统方面发挥作用。我们证明 HLA-DRB103 等位基因可能是 BK 病毒的一个危险因素。该等位基因可能与免疫系统免疫调节细胞因子的分泌有关。